Please Wait.....
Report
Global Biological Buffers Market
Market Report I 2025-03-01 I 350 Pages I Data Bridge Market Research
DESCRIPTION
Short Description
Global Biological Buffers Market, By Buffers Type (Goods Buffers, Other Salt-Based Buffers), Formulation (Powder, Liquid), Application (Pharmaceutical & Biopharmaceuticals, Cell Culture & Molecular Biology, Clinical & Diagnostic Applications, Chemical & Industrial Applications, Others), End User (Pharmaceutical & Biopharmaceutical Companies, Biotechnology Companies, Research & Academic Institutes, Diagnostic Laboratories, Contract Research Organizations (CROs) & CMOs), Country (U.S., Canada, Mexico, Germany, U.K., France, Italy, Spain, Russia, Netherlands, Switzerland, Turkey, Austria, Poland, Ireland, Norway, Rest of Europe, Japan, China, South Korea, India, Singapore, Thailand, Indonesia, Malaysia, Philippines, Australia, New Zealand, Taiwan, Rest of Asia-Pacific, Brazil, Argentina, Chile, Peru, Rest of South America, South Africa, Saudi Arabia, UAE, Egypt, Kuwait, Israel, Rest Of Middle East And Africa) - Industry Trends and Forecast to 2035
Market Definition
Biological buffers are solutions containing a weak acid and its conjugate base (or a weak base and its conjugate acid) that resist changes in pH upon the addition of an acid or base. They are crucial in biological systems and laboratory settings to maintain a stable pH environment, as enzymes and other biomolecules are highly sensitive to pH fluctuations. Common biological buffers include phosphate, Tris, and HEPES, each with a specific buffering range suitable for different applications.
Market Segmentation
Global biological buffers market is categorized into four notable segments based on buffer type, formulation, application, and end user
- On the basis of buffer type, the market is segmented into Goods Buffers, Other Salt-Based Buffers
- On the basis of formulation, the market is segmented into Powder, Liquid
- On the basis of application, the market is segmented into Pharmaceutical & Biopharmaceuticals, Cell Culture & Molecular Biology, Clinical & Diagnostic Applications, Chemical & Industrial Applications, Others
- On the basis of end user, the market is segmented into Pharmaceutical & Biopharmaceutical Companies, Biotechnology Companies, Research & Academic Institutes, Diagnostic Laboratories, Contract Research Organizations (CROs) & CMOs
Market Players
The key players operating in the global biological buffers market are:
- F. Hoffmann-La Roche Ltd
- Bio-Rad Laboratories, Inc.
- Thermo Fisher Scientific Inc.
- Takara Bio Inc.
- Merck KGaA
- Avantor, Inc.
- Advancion Corporation
- Santa Cruz Biotechnology Inc.
- MP Biomedicals.
- Promega Corporation
- Beckman Coulter, Inc.
- QIAGEN
- HiMedia Laboratories
- Cayman Chemical
- Biosynth
- SERVA Electrophoresis GmbH
- FUJIFILM Wako Pure Chemical Corporation
- Reagecon Diagnostics Ltd
- GoldBio
- nacalai.com.
- HOPAX
TABLE OF CONTENTS
1 INTRODUCTION 54
1.1 OBJECTIVES OF THE STUDY 54
1.2 MARKET DEFINITION 54
1.3 OVERVIEW OF THE GLOBAL BIOLOGICAL BUFFERS MARKET 54
1.4 LIMITATIONS 55
1.5 MARKETS COVERED 55
2 MARKET SEGMENTATION 59
2.1 MARKETS COVERED 59
2.2 GEOGRAPHICAL SCOPE 60
2.3 YEARS CONSIDERED FOR THE STUDY 61
2.4 CURRENCY AND PRICING 61
2.5 DBMR TRIPOD DATA VALIDATION MODEL 62
2.6 MULTIVARIATE MODELLING 65
2.7 TYPE LIFELINE CURVE 65
2.8 PRIMARY INTERVIEWS WITH KEY OPINION LEADERS 66
2.9 DBMR MARKET POSITION GRID 67
2.10 MARKET END USER COVERAGE GRID 68
2.11 VENDOR SHARE ANALYSIS 69
2.12 SECONDARY SOURCES 70
2.13 ASSUMPTIONS 70
3 EXECUTIVE SUMMARY 71
4 PREMIUM INSIGHTS 73
5 GLOBAL BIOLOGICAL BUFFER MARKET: REGULATIONS 79
5.1 REGULATORY AUTHORITIES IN THE U.S. 79
5.2 REGULATORY SUBMISSIONS 86
5.3 INTERNATIONAL HARMONIZATION 86
5.4 EUROPE REGULATORY SCENARIO 87
5.5 REGULATORY SUBMISSIONS 89
5.6 INTERNATIONAL HARMONIZATION 90
5.7 JAPAN REGULATORY SCENARIO 92
5.8 REGULATORY SUBMISSIONS 94
5.9 INTERNATIONAL HARMONIZATION 95
5.10 COMPLIANCE AND QUALITY MANAGEMENT SYSTEMS 96
?
6 MARKET OVERVIEW 99
6.1 DRIVERS 101
6.1.1 RISING PREVALENCE OF CHRONIC DISEASES 101
6.1.2 INCREASED ADOPTION OF WESTERN BLOT AND ELISA TECHNIQUES 101
6.1.3 TECHNOLOGICAL ADVANCEMENTS IN ASSAY DEVELOPMENT 102
6.1.4 ADVANCEMENTS IN PROTEOMICS AND GENOMICS 103
6.2 RESTRAINTS 104
6.2.1 LIMITED SHELF LIFE OF BLOCKING BUFFERS 104
6.2.2 POTENTIAL OF CONTAMINATION OR BATCH INCONSISTENCIES FOR BIOLOGICAL BUFFERS 104
6.3 OPPORTUNITY 105
6.3.1 INCREASE IN PUBLIC-PRIVATE FUNDING IN BIOMEDICAL RESEARCH 105
6.3.2 ANALYTICAL METHODS FOR FOOD SAFETY AND ENVIRONMENTAL TESTING. 106
6.3.3 DIAGNOSTIC AND CLINICAL APPLICATIONS USE BLOCKING BUFFERS. 106
6.4 CHALLENGES 107
6.4.1 ALTERNATIVE TECHNOLOGIES AND APPROACHES FOR INHIBITING BIOLOGICAL BUFFERS. 107
6.4.2 DISRUPTIONS IN THE SUPPLY CHAIN OF BIOLOGICAL BUFFERS. 108
7 GLOBAL BIOLOGICAL BUFFERS MARKET, BY BUFFERS TYPE 109
7.1 OVERVIEW 110
7.2 GOODS BUFFERS 113
7.2.1 TRIS BUFFERS 114
7.2.2 HEPES BUFFERS 115
7.2.3 MOPS BUFFERS 116
7.2.4 MES BUFFERS 116
7.2.5 BIS-TRIS BUFFERS 117
7.3 OTHER SALT-BASED BUFFERS 118
7.3.1 PHOSPHATE BUFFERS 119
7.3.2 ACETATE BUFFERS 120
7.3.3 CITRATE BUFFERS 120
7.3.4 AMINO ACID BUFFERS 120
8 GLOBAL BIOLOGICAL BUFFERS MARKET, BY FORMULATION 122
8.1 OVERVIEW 123
8.2 POWDER 126
8.3 LIQUID 127
9 GLOBAL BIOLOGICAL BUFFERS MARKET, BY APPLICATION 128
9.1 OVERVIEW 129
9.2 PHARMACEUTICAL & BIOPHARMACEUTICALS 132
9.3 CELL CULTURE & MOLECULAR BIOLOGY 134
9.4 CLINICAL & DIAGNOSTIC APPLICATIONS 136
9.5 CHEMICAL & INDUSTRIAL APPLICATIONS 138
9.6 OTHERS 139
10 GLOBAL BIOLOGICAL BUFFERS MARKET, BY END USER 140
10.1 OVERVIEW 141
10.2 PHARMACEUTICAL & BIOPHARMACEUTICAL COMPANIES 145
10.3 BIOTECHNOLOGY COMPANIES 146
10.4 RESEARCH & ACADEMIC INSTITUTES 147
10.5 DIAGNOSTIC LABORATORIES 148
10.6 CONTRACT RESEARCH ORGANIZATIONS (CROS) & CMOS 149
11 GLOBAL BIOLOGICAL BUFFERS MARKET, BY REGION 150
11.1 OVERVIEW 151
11.2 NORTH AMERICA 154
11.2.1 U.S 163
11.2.2 CANADA 172
11.2.3 MEXICO 181
11.3 EUROPE 189
11.3.1 GERMANY 200
11.3.2 U.K 209
11.3.3 FRANCE 218
11.3.4 ITALY 227
11.3.5 SPAIN 236
11.3.6 RUSSIA 244
11.3.7 SWITZERLAND 260
11.3.8 TURKEY 268
11.3.9 AUSTRIA 275
11.3.10 POLAND 282
11.3.11 IRELAND 289
11.3.12 NORWAY 296
11.3.13 REST OF EUROPE 303
11.4 ASIA-PACIFIC 304
11.4.1 JAPAN 314
11.4.2 CHINA 323
11.4.3 SOUTH KOREA 332
11.4.4 INDIA 341
11.4.5 SINGAPORE 350
11.4.6 THAILAND 358
11.4.7 INDONESIA 366
11.4.8 MALAYSIA 373
11.4.9 PHILIPPINES 380
11.4.10 AUSTRALIA 387
11.4.11 NEW ZEALAND 394
11.4.12 TAIWAN 401
11.4.13 REST OF ASIA-PACIFIC 408
11.5 MIDDLE EAST AND AFRICA 409
11.5.1 SOUTH AFRICA 419
11.5.2 SAUDI ARABIA 427
11.5.3 UAE 434
11.5.4 EGYPT 441
11.5.5 KUWAIT 448
11.5.6 ISRAEL 455
11.5.7 REST OF MIDDLE EAST AND AFRICA 462
11.6 SOUTH AMERICA 463
11.6.1 BRAZIL 472
11.6.2 ARGENTINA 480
11.6.3 CHILE 488
11.6.4 PERU 495
11.6.5 REST OF SOUTH AMERICA 502
12 GLOBAL BIOLOGICAL BUFFERS MARKET: COMPANY LANDSCAPE 503
12.1 COMPANY SHARE ANALYSIS: GLOBAL 503
12.2 COMPANY SHARE ANALYSIS: NORTH AMERICA 504
12.3 COMPANY SHARE ANALYSIS: EUROPE 505
12.4 COMPANY SHARE ANALYSIS: ASIA-PACIFIC 506
13 SWOT 507
14 COMPANY PROFILES 508
14.1 F. HOFFMANN-LA ROCHE LTD 508
14.1.1 COMPANY SNAPSHOT 508
14.1.2 REVENUE ANALYSIS 508
14.1.3 COMPANY SHARE ANALYSIS 509
14.1.4 PRODUCT PORTFOLIO 509
14.1.5 RECENT UPDATES 510
14.2 BIO-RAD LABORATORIES, INC. 511
14.2.1 COMPANY SNAPSHOT 511
14.2.2 REVENUE ANALYSIS 511
14.2.3 COMPANY SHARE ANALYSIS 512
14.2.4 PRODUCT PORTFOLIO 512
14.2.5 RECENT DEVELOPMENT 512
14.3 THERMO FISHER SCIENTIFIC, INC. 513
14.3.1 COMPANY SNAPSHOT 513
14.3.2 REVENUE ANALYSIS 513
14.3.3 COMPANY SHARE ANALYSIS 514
14.3.4 PRODUCT PORTFOLIO 514
14.3.5 RECENT UPDATES 518
14.4 TAKARA BIO INC. 519
14.4.1 COMPANY SNAPSHOT 519
14.4.2 REVENUE ANALYSIS 519
14.4.3 COMPANY SHARE ANALYSIS 520
14.4.4 PRODUCT PORTFOLIO 520
14.4.5 RECENT DEVELOPMENTS 521
14.5 MERCK KGAA, DARMSTADT, GERMANY 522
14.5.1 COMPANY SNAPSHOT 522
14.5.2 REVENUE ANALYSIS 522
14.5.3 COMPANY SHARE ANALYSIS 523
14.5.4 PRODUCT PORTFOLIO 523
14.5.5 RECENT DEVELOPMENTS 523
14.6 ADVANCION CORPORATION 525
14.6.1 COMPANY SNAPSHOT 525
14.6.2 PRODUCT PORTFOLIO 525
14.6.3 RECENT DEVELOPMENT 526
14.7 AVANTOR, INC. 527
14.7.1 COMPANY SNAPSHOT 527
14.7.2 REVENUE ANALYSIS 527
14.7.3 PRODUCT PORTFOLIO 528
14.7.4 RECENT DEVELOPMENT 529
14.8 BECKMAN COULTER 530
14.8.1 COMPANY SNAPSHOT 530
14.8.2 PRODUCT PORTFOLIO 530
14.8.3 RECENT DEVELOPMENT 530
14.9 BIOSYNTH 531
14.9.1 COMPANY SNAPSHOT 531
14.9.2 PRODUCT PORTFOLIO 531
14.9.3 RECENT DEVELOPMENT 532
14.10 FUJIFILM WAKO PURE CHEMICAL CORPORATION 533
14.10.1 COMPANY SNAPSHOT 533
14.10.2 PRODUCT PORTFOLIO 533
14.10.3 RECENT DEVELOPMENT 535
14.11 GOLDBIO 536
14.11.1 COMPANY SNAPSHOT 536
14.11.2 PRODUCT PORTFOLIO 536
14.11.3 RECENT DEVELOPMENT 538
14.12 HOPAX 539
14.12.1 COMPANY SNAPSHOT 539
14.12.2 PRODUCT PORTFOLIO 539
14.12.3 RECENT DEVELOPMENT 541
14.13 HIMEDIA LABORATORIES 542
14.13.1 COMPANY SNAPSHOT 542
14.13.2 PRODUCT PORTFOLIO 542
14.13.3 RECENT DEVELOPMENT 543
14.14 MP BIOMEDICALS. 544
14.14.1 COMPANY SNAPSHOT 544
14.14.2 PRODUCT PORTFOLIO 544
14.14.3 RECENT DEVELOPMENT 545
14.15 NACALAI TESQUE, INC. 546
14.15.1 COMPANY SNAPSHOT 546
14.15.2 PRODUCT PORTFOLIO 546
14.15.3 RECENT DEVELOPMENT 548
14.16 PROMEGA CORPORATION 550
14.16.1 COMPANY SNAPSHOT 550
14.16.2 PRODUCT PORTFOLIO 550
14.16.3 RECENT DEVELOPMENT 551
14.17 QIAGEN 552
14.17.1 COMPANY SNAPSHOT 552
14.17.2 REVENUE ANALYSIS 552
14.17.3 PRODUCT PORTFOLIO 553
14.17.4 RECENT DEVELOPMENT 553
14.18 REAGECON DIAGNOSTICS LTD 554
14.18.1 COMPANY SNAPSHOT 554
14.18.2 PRODUCT PORTFOLIO 554
14.18.3 RECENT DEVELOPMENT 556
14.19 SANTA CRUZ BIOTECHNOLOGY INC. 557
14.19.1 COMPANY SNAPSHOT 557
14.19.2 PRODUCT PORTFOLIO 557
14.19.3 RECENT DEVELOPMENT 559
14.20 SERVA ELECTROPHORESIS GMBH 560
14.20.1 COMPANY SNAPSHOT 560
14.20.2 PRODUCT PORTFOLIO 560
14.20.3 RECENT DEVELOPMENT 560
14.21 TEVA PHARMACEUTICALS USA, INC. 561
14.21.1 COMPANY SNAPSHOT 561
14.21.2 REVENUE ANALYSIS 561
14.21.3 PRODUCT PORTFOLIO 562
14.21.4 RECENT DEVELOPMENT 563
15 QUESTIONNAIRE 564
16 RELATED REPORTS 567
?
- Not Sure / Need Reassuring
- Confirm Content
-
Content is provided by our partners and every effort is made to make Market Report details as clear as possible. If you are not sure the exact content you require is included in this study you can Contact us to double check. To do this you can:
Use the ‘? ASK A QUESTION’ below the license / prices and to the right of this box. This will come directly to our team who will work on dealing with your request as soon as possible.
Write to directly on support@scotts-international.com with details. Please include as much information as possible including the name of report or link so our staff will be able to work on you request.
Telephone us directly on 0048 603 394 346 and an experienced member of team will be on hand to answer.
-
- Sample Pages
-
With the vast majority of our partners we can obtain Sample Pages to support your decision. This is something we can arrange without revealing your personal details.
It is important to note that we will not be able to provide you the exact data or statistics such as Market Size and Forecasts. Sample pages usually confirm the layout or the Categories included in Charts and Graphs, excluding specific data.
To ask for Sample Pages by contact us through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346.
-
- Check for Alternatives
-
Whilst we try to make our online platform as easy to use as possible there is always the possibility that a better alternative has not been found in your search.
To avoid this possibility Contact us through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346 and a Senior Team Member can review your requirements and send a list of possibilities with opinions and recommendations.
-
- Confirm Content
- Prices / Formats / Delivery
- Prices
-
All prices are set by our partners and should be exactly the same as those listed on their own websites. We work on a Revenue share basis ensuring that you never pay more than what is offered elsewhere.
Should you find the price cheaper on another platform we recommend you to Contact us as we should be able to match this price. You can Contact us though through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346.
-
- Discounts
-
As we work in close partnership with our Partners from time to time we can secure discounts and assist with negotiations, this is part of our personalised service to you.
Discounts can sometimes be arranged for speedily placed orders; multiple report purchases or Higher License purchases.
To check if a Discount is possible please Contact our experienced team through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346.
-
- Available Currencies
-
Most Market Reports on our platform are listed in USD or EURO based on the wishes of our Partners. To avoid currency fluctuations and potential price differentiations we do not offer the possibility to change the currency online.
Should you wish to pay in a different currency to that advertised online we do accept payments in USD, EURO, GBP and PLN. The price will be calculated based on the relevant exchange rate taken from our National Bank.
To pay in a different above currency to that advertised online please Contact our team and a quotation will be sent within a couple of hours with payment details.
-
- Licenses
-
License options vary from Partner to Partner as is usually based on the number of Users that will benefitting from the report. It is very important that License ordered is not breached as this could have potential negative consequences for you individually or your employer.
If you have questions or need confirmation about the specific license we recommend you to Contact us and a detailed explanation will be provided.
-
- Global Site License
-
The Global Site License is the most comprehensive license available. By selecting this license, the Market Report can be shared with other ‘Allowed Users’ and any other member of staff from the same organisation regardless of geographic location.
It is important to note that this may exclude Parent Companies or Subsidiaries.
If you have questions or need confirmation about the specific license we recommend you to Contact us and a detailed explanation will be provided.
-
- Formats
-
The most common format is PDF, however in certain circumstances data may be present in Excel format or Online, especially in the case of Database or Directories. In addition, for certain higher license options a CD may also be provided.
If you have questions or need clarification about the specific formats we recommend you to Contact us and a detailed explanation will be provided.
-
- Delivery
-
Delivery is fulfilled by our partners directly. Once an order has been placed we inform the partner by sharing the delivery email details given in the order process.
Delivery is usually made within 24 hours of an order being placed, however it may take longer should your order be placed prior to the weekend or if otherwise specified on the Market Report details page. Additionally, if details have been not fully completed in the Order process a delay in delivery is possible.
If a delay in delivery is expected you will be informed about it immediately.
-
- Shipping Charges
-
As most Market Reports are delivered in PDF format we almost never have to add additional Shipping Charges. If, however you are ordering a Higher License service or a specific delivery format (e.g. CD version) charges may apply.
If you are concerned about additional Shipping Charges we recommend you to Contact us to double check.
-
- Prices
- Ordering
- By Credit Card
-
We work in Partnership with PayU to ensure payments are made securely in a fast and effortless way. PayU is the e-payments division of Naspers.
Naspers operates in over 133 International Markets and ranks 3rd Globally in terms of the number of e-commerce customers served.
For more information on PayU please visit: https://www.payu.pl/en/about-us
-
- By Money Transfer
-
If you require an invoice prior to payment, this is possible. To ensure a speedy delivery of the Market Report we require all relevant company details and you agree to maximum payment terms of 30 days from receipt of order.
With our regular clients deliver of the Market Report can be made prior to receiving payment, however in some circumstances we may ask for payment to be received before arranging for the Market Report to be delivered.
-
- By Credit Card
- Security
- Website security
-
We have specifically partnered with leading International companies to protect your privacy by using different technologies and processes to ensure security.
Everything submitted to Scotts International is encrypted via SSL (Secure Socket Layer) and all personal information provided to Scotts International is stored on computer systems with limited access in controlled environments.
-
- Credit Card Security
-
We partner with PayU (https://www.payu.pl/en/about-us) to ensure all credit card payments are made securely in a fast and effortless way.
PayU offers 250+ various payment channels and eWallet services across 4 continents allowing buyers to pay electronically, whether on a computer or a mobile device.
-
- Website security